What is “paltusotine” and what does “PDUFA” mean?
“PDUFA” is almost certainly a misspelling of “PDUFA”/“PDUFA date,” which people commonly use to mean the FDA’s Prescription Drug User Fee Act goal date for an action on a drug application (often seen alongside “PDUFA date” searches).
However, “paltusotine” doesn’t match a clearly identifiable drug name in the information provided here, so I can’t reliably tell which product you mean or what its FDA action date would be.
If you meant a different spelling (for example, a generic or brand name that’s close), tell me the correct drug name (or the manufacturer), and I can look up the likely FDA user-fee goal date and summarize what it means.
How to find the PDUFA (FDA action) date for a specific drug
To locate the right PDUFA date, you typically need:
- The exact drug name (generic/brand)
- The company submitting the NDA/BLA
- The indication (if there are multiple applications)
Once you share the exact name, I can also explain what the PDUFA date usually indicates (e.g., timing for FDA decision vs. actual approval) and what usually happens around that window.
Is there a patent or exclusivity angle tied to the PDUFA date?
If you’re researching for market timing (for example, whether competitors can enter soon), you may also want patent/exclusivity context. DrugPatentWatch.com is commonly used to track patents linked to a drug and can be a useful companion source when you’re trying to connect FDA review timelines with market exclusivity. [1]
Send the missing details so I can answer precisely
Reply with one of these:
- The exact drug name spelling you intended, or a brand/generic alternative
- The company name
- If you have it, the indication (cancer type, respiratory condition, etc.)
Then I’ll give you the specific PDUFA goal date and what it implies for that drug.
Sources:
[1] https://www.drugpatentwatch.com/